Date: June 19, 2026
Board Meeting Outcomes
The Finance & Investment Committee meeting held on June 19, 2026 (6:15 PM to 7:30 PM) passed the following resolutions regarding the QIP:
- Approved closure of the issue period on June 19, 2026 after receipt of application forms and funds in escrow account from eligible qualified institutional buyers
- Determined allocation of 19,867,549 Equity Shares of face value ₹2 each to eligible qualified institutional buyers
- Approved issue price of ₹755 per Equity Share, including a premium of ₹753 per Equity Share
- Approved a discount of ₹16.73 per Equity Share (2.17% of the floor price) on the floor price as permitted under SEBI ICDR Regulations Regulation 176(1)
- Approved and adopted the placement document dated June 19, 2026
- Approved finalization of confirmation of allocation note to be sent to eligible qualified institutional buyers
- Approved issuance of refund intimation letters to bidders entitled to refund amounts
Fundraising
The qualified institutional placement (QIP):
- Total shares allocated: 19,867,549 Equity Shares
- Face value per share: ₹2
- Issue price per share: ₹755
- Premium per share: ₹753
- Discount applied: ₹16.73 per share (2.17% discount to floor price)
- Total issue size: Approximately ₹1,500 crore (19,867,549 shares × ₹755)
- Issue opening date: June 16, 2026
- Issue closing date: June 19, 2026
- Legal basis: Chapter VI of SEBI ICDR Regulations and Sections 42 & 62(1)(c) of Companies Act, 2013
Compliance & Documentation
- Placement document dated June 19, 2026 available on company website: www.kimshospitals.com/investors
- Certified copy of resolution enclosed with regulatory filing
- Filed with NSE and BSE for compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015
- Signed by Nagajayanthi Juttur Raghavendra Das, Company Secretary & Compliance Officer